B+
Bull case
20%
Probability
Target price
$0.38
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
GOVX
GeoVax LabsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
On-time GEO-MVA study initiation, sustained listing, and funding on tolerable terms could improve the case. The CEPI laboratory agreement supports study preparation, not efficacy or procurement.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
GEO-MVA study initiation may slip or require additional capital; initiation would not be a clinical readout or approval.
Momentum
79
Value
59
Sentiment
56
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.19 · Bull $0.38 · Bear $0.06Analysis 2026-10-20; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-29 • Vendor: Data Vendor v1
Scores
As of 2026-10-29 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-20 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-29
Investment thesis
As of 2026-10-29
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-29. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $10.00
Why
Momentum79 · Δ7d -
Value59 · Δ7d -0.1
Sentiment56 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.1.
Contradictions & invalidation
- • GEO-MVA study initiation may slip or require additional capital; initiation would not be a clinical readout or approval.
- • Micro-cap liquidity and loose valuation peers limit confidence in price targets.
- • Unresolved listing status, uncertain post-August cash runway, potential warrant dilution, and study delays could overwhelm clinical-program progress.
Catalyst clock
2026-10-27
October 27 shareholder vote
Lead driver: Value · See fundamentals
Momentum
79
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
59
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+17.8
Sentiment
56
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 78.7 / Value 58.7 / Sentiment 56.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-20. Scenario method
Most likely
B
Base case
40%
Probability
Target price
$0.19
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
B-
Bear case
40%
Probability
Target price
$0.06
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-29
Fundamentals (TTM)
As of 2026-10-29
Market Cap
$1.88M
Beta
3.77
Shares Out
10.1M
P/E (TTM) · Derived
-0.0
P/S (TTM)
2.45
P/FCF (TTM) · Derived
-0.01
Rev YoY
-100.0%
EPS YoY
-88.9%
Gross Margin
+98.3%
Op Margin
-761.6%
Net Debt
-$2.24M
Current Ratio
1.54
As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data